Chemically defined generation of human cardiomyocytes

Burridge, Paul W, Matsa, Elena, Shukla, Praveen, Lin, Ziliang C, Churko, Jared M, Ebert, Antje D, Lan, Feng, Diecke, Sebastian +7 more·2014·Nature Methods
DOI 10.1038/nmeth.2999

Cited by (1,001)

Items 901–1,000 of 1,001

  1. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment
    Arvin H. Soepriatna, Tae Yun Kim, Mark C. Daley, Elena Song, Bum‐Rak Choi, Kareen L. K. Coulombe · 2021 · Cellular and Molecular Bioengineering
  2. Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes
    Yukihiro Saito, Kazufumi Nakamura, Masashi Yoshida, Hiroki Sugiyama, Satoshi Akagi, Toru Miyoshi, Hiroshi Morita, Hiroshi Ito · 2022 · Stem Cell Research & Therapy
  3. Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues
    Arvin H. Soepriatna, Allison Navarrete-Welton, Tae Yun Kim, Mark C. Daley, Peter Bronk, Celinda M. Kofron, Ulrike Mende, Kareen L. K. Coulombe, Bum‐Rak Choi · 2023 · PLoS ONE
  4. Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method
    Isaiah K. Mensah, Martin L. Emerson, Hern J. Tan, Humaira Gowher · 2024 · Cells
  5. PLEKHM2 deficiency induces impaired mitochondrial clearance and elevated ROS levels in human iPSC-derived cardiomyocytes
    Jianchao Zhang, Ying Peng, Wanrong Fu, Ruifei Wang, Jinhua Cao, Shuang Li, Xiaoxu Tian, Zhonggen Li, Chongpei Hua, Yafei Zhai et al. · 2024 · Cell Death Discovery
  6. Volumetric trans-scale imaging of massive quantity of heterogeneous cell populations in centimeter-wide tissue and embryo
    Taro Ichimura, Taishi Kakizuka, Yasuhito Taniguchi, Satoshi Ejima, Yuki Sato, Keiko Itano, Kaoru Seiriki, Hitoshi Hashimoto, Ko Sugawara, Hiroya Itoga et al. · 2024 · eLife
  7. Generation of PDGFRα+ Cardioblasts from Pluripotent Stem Cells
    Seon Pyo Hong, Sukhyun Song, Sung Woo Cho, Seungjoo Lee, Bong Ihn Koh, Hosung Bae, Kyun Hoo Kim, Jin-Sung Park, Hyo‐Sang Do, Ilkyun Im et al. · 2017 · Scientific Reports
  8. The Future Role of Pharmacogenomics in Anticancer Agent-Induced Cardiovascular Toxicity
    Tarek Magdy, Paul W. Burridge · 2017 · Pharmacogenomics
  9. Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing
    Richard P. Harrison, Hilda Anaid Lugo Leija, Stephanie Strohbuecker, James Crutchley, Sarah Marsh, Chris N. Denning, Alicia Jennifer El Haj, Virginie Sottile · 2018 · Stem Cell Research & Therapy
  10. Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
    Wenbin Liang, Lilit Gasparyan, Wael Alqarawi, Darryl Raymond Davis · 2019 · Expert Opinion on Biological Therapy
  11. Genetic variants in TRPM7 associated with unexplained stillbirth modify ion channel function
    James Cartwright, Qadeer H. Aziz, Stephen C. Harmer, Sudhin Thayyil, Andrew Tinker, Patricia B. Munroe · 2019 · Human Molecular Genetics
  12. Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine
    Martha E. Floy, Taylor D. Mateyka, Koji L. Foreman, Sean P. Palecek · 2020 · Stem Cell Research
  13. INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.
    Chrishan J. A. Ramachandra, K.P. Myu Mai Ja, Ying‐Hsi Lin, WINSTON S. N. SHIM, William A. Boisvert, Derek John Hausenloy · 2019 · PubMed
  14. Modeling the Response of Heart Muscle to Mechanical Stimulation In Vitro
    Jingxuan Guo, Nathaniel Huebsch · 2020 · Current Tissue Microenvironment Reports
  15. From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
    Mariana A. Branco, Joaquim M. S. Cabral, Maria Margarida Diogo · 2020 · Bioengineering
  16. Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes
    Aleksandra Nijak, Eline Simons, Bert Vandendriessche, Dieter V. Van de Sande, Erik Fransén, Ewa Sieliwończyk, Ilse Van Gucht, Emeline M. Van Craenenbroeck, Johan B. Saenen, Hein Heidbüchel et al. · 2022 · Biology Open
  17. MYOCD is Required for Cardiomyocyte-like Cells Induction from Human Urine Cells and Fibroblasts Through Remodeling Chromatin
    Xiangyu Zhang, Lijun Chen, Xingnan Huang, Huan Chen, Baomei Cai, Yue Qin, Yating Chen, Sihua Ou, Xiaoxi Li, Zichao Wu et al. · 2022 · Stem Cell Reviews and Reports
  18. Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)
    Luca Sala, Dorien Ward‐van Oostwaard, Leon G.J. Tertoolen, Christine L. Mummery, Milena Bellin · 2017 · Journal of Visualized Experiments
  19. Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
    Adriana Bastos Carvalho, Keyla Cristiny da Silva Coutinho, Raiana Andrade Quintanilha Barbosa, Dilza Balteiro Pereira de Campos, Isabela de Carvalho Leitão, Rafael Serafim Pinto, Danúbia Silva dos Santos, Bruna Farjun, Dayana S. Araujo, Fernanda Mesquita et al. · 2022 · Frontiers in Physiology
  20. Deciphering the Cardiovascular Potential of Human CD34+ Stem Cells
    Anne Aries, Céline Zanetti, Philippe R.G. Henon, Bernard Drénou, Rachid Lahlil · 2023 · International Journal of Molecular Sciences
  21. Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7
    Huijun Yang, Shen Song, Jiacheng Li, Yandong Li, Jie Feng, Quan Xi Sun, Xueting Qiu, Ziwei Chen, Xue Bai, Xinchang Liu et al. · 2023 · Cellular and Molecular Life Sciences
  22. Long non-coding RNA LHX1-DT regulates cardiomyocyte differentiation through H2A.Z-mediated LHX1 transcriptional activation
    Qi Yu, Benzhi Cai, Yong Zhang, Juan Xu, Dongping Liu, Zhenbo Han, Zhenbo Han, Yingying Ma, Lei Jiao, Manyu Gong et al. · 2023 · iScience
  23. COX6A2 deficiency leads to cardiac remodeling in human pluripotent stem cell-derived cardiomyocytes
    Mengqi Jiang, Yuanxiu Song, Xi Chen, Wenjing Lü, Min Zhu, Mingyu Wei, Feng Lan, Ming Cui, Yun Bai · 2023 · Stem Cell Research & Therapy
  24. Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound
    Lotta Pohjolainen, Sini M. Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T. Yli‐Kauhaluoma, Virpi Talman et al. · 2024 · Stem Cell Research & Therapy
  25. Human sodium current voltage‐dependence at physiological temperature measured by coupling a patch‐clamp experiment to a mathematical model
    Veronika O. Abrasheva, Kovalenko Sandaara, М. М. Slotvitsky, Serafima Scherbina, Aleria A. Aitova, Sheida R. Frolova, V. A. Tsvelaya, Roman A. Syunyaev · 2024 · The Journal of Physiology
  26. Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist Fenofibrate
    Seul-Gi Lee, Jooeon Rhee, Jin Seok, Jin Hee Kim, Min Woo Kim, Gyeong-Eun Song, Shinhye Park, Kyu Sik Jeong, Suemin Lee, Yun Hyeong Lee et al. · 2024 · Stem Cells Translational Medicine
  27. LMNA-Related Dilated Cardiomyopathy: Single-Cell Transcriptomics during Patient-Derived iPSC Differentiation Support Cell Type and Lineage-Specific Dysregulation of Gene Expression and Development for Cardiomyocytes and Epicardium-Derived Cells with Lamin A/C Haploinsufficiency
    Michael V. Zaragoza, Thuy-Anh Bui, Halida P. Widyastuti, Mehrsa Mehrabi, Zixuan Cang, Yutong Sha, Anna Grosberg, Qing Hua Nie · 2024 · Cells
  28. Transcriptomic Insights into the Atrial Fibrillation Susceptibility Locus near the MYOZ1 and SYNPO2L Genes
    Sojin Youn Wass, Han Sun, Gregory Tchou, Nana Liu, David R. Van Wagoner, Mina K. Chung, John Barnard, Jonathan D. Smith · 2024 · International Journal of Molecular Sciences
  29. Transformative Potential of Induced Pluripotent Stem Cells in Congenital Heart Disease Research and Treatment
    Mohammed A. Mashali, Isabelle Deschênes, Nancy S. Saad · 2025 · Children
  30. Current status and future prospects of toxicity assessment using organoids
    Xuan‐Hung Nguyen, Jongman Yoo · 2025 · Toxicological Research
  31. Advancing organ-on-chip systems: the role of microfluidics in neuro-cardiac research
    Maria João Ferreira, Sarah Colombani, Albin A. Bernardin, Alain Lacampagne, Jean‐Luc Pasquié, Pedro F. Costa, Benoît Charlot, Albano C. Méli · 2025 · Current Research in Pharmacology and Drug Discovery
  32. W-7 inhibits voltage-dependent K+ channels independent of calmodulin activity in rabbit coronary arterial smooth muscle cells
    Hongliang Li, Il‐Whan Choi, Da Hye Hong, Youn Kyoung Son, Sung Hun Na, Won‐Kyo Jung, Amy L. Firth, In Duk Jung, Yeong‐Min Park, Won Sun Park · 2015 · European Journal of Pharmacology
  33. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum
    Kwang Bo Jung, Ye Seul Son, Hana Lee, Cho‐Rok Jung, Janghwan Kim, Mi‐Young Son · 2017 · Molecular BioSystems
  34. Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns
    Eric Jabart, Josh Molho, Kristina Sin, Ben N. Stansfield, Sobhi G. Kazmouz, Daniela Ventro, Kelly Gardner, Joseph C. Wu, Jared M. Churko · 2020 · Journal of Molecular and Cellular Cardiology
  35. Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes
    Kyla Bourque, Cara Hawey, Jace Jones-Tabah, Darlaine Pétrin, Ryan Martin, Yi Sun, Terence E. Hébert · 2021 · Methods
  36. Stimulation of Cardiomyocyte Proliferation Is Dependent on Species and Level of Maturation
    Doğacan Yücel, Bayardo I. Garay, Rita C. R. Perlingeiro, Jop H. van Berlo · 2022 · Frontiers in Cell and Developmental Biology
  37. Ectopic expression of SARS-CoV-2 S and ORF-9B proteins alters metabolic profiles and impairs contractile function in cardiomyocytes
    Peng Zhang, Yu Liu, Chunfeng Li, Lindsay Stine, Pei‐Hui Wang, Matthew W. Turnbull, Haodi Wu, Qing Liu · 2023 · Frontiers in Cell and Developmental Biology
  38. Automated assessment of human engineered heart tissues using deep learning and template matching for segmentation and tracking
    José M. Rivera‐Arbeláez, Danjel Keekstra, Carla Cofiño‐Fabrés, Tom Boonen, Milica Dostanić, Simone A. ten Den, Kim Vermeul, Massimo Mastrangeli, Albert van den Berg, Loes Irene Segerink et al. · 2023 · Bioengineering & Translational Medicine
  39. iPSC-Derived Glioblastoma Cells Have Enhanced Stemness Wnt/β-Catenin Activity Which Is Negatively Regulated by Wnt Antagonist sFRP4
    Ishmat Ara Yasmin, Arun Dharmarajan, Sudha R. Warrier · 2023 · Cancers
  40. Harnessing developmental cues for cardiomyocyte production
    Renée G. C. Maas, Floor W. van den Dolder, Qianliang Yuan, Jolanda van der Velden, Sean M. Wu, Joost P. G. Sluijter, Jan Willem Buikema · 2023 · Development
  41. Induced pluripotent stem cell technology and inherited arrhythmia syndromes
    Samantha Barratt Ross, Stuart T. Fraser, Christopher Semsarian · 2017 · Heart Rhythm
  42. Single-Cell Sequencing Technologies for Cardiac Stem Cell Studies
    Tiantian Liu, Hongjin Wu, Shixiu Wu, Charles Wang · 2017 · Stem Cells and Development
  43. Extracellular MicroRNAs and Mitochondrial DNA as Potential Biomarkers of Arrhythmogenic Cardiomyopathy
    Aleksandr A. Khudiakov, Natalia Smolina, Kseniya Perepelina, Anna Malashicheva, Anna Aleksandrovna Kostareva · 2019 · Biochemistry (Moscow)
  44. Challenging the “chromatin hypothesis” of cardiac laminopathies with LMNA mutant iPS cells
    Chiara Mozzetta, Francesco Saverio Tedesco · 2019 · The Journal of Cell Biology
  45. MiR-499 Responsive Lethal Construct for Removal of Human Embryonic Stem Cells after Cardiac Differentiation
    Edan Elovic, Sharon Etzion, Smadar Cohen · 2019 · Scientific Reports
  46. Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties
    Yifeng Nie, He Yin, Dong Han, Yuansheng Liu, Xiang Li · 2020 · Scientific Reports
  47. Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity
    Tarek Magdy, Paul W. Burridge · 2021 · Pharmacogenomics
  48. Improved nanopore direct RNA sequencing of cardiac myocyte samples by selective mt-RNA depletion
    Isabel S. Naarmann‐de Vries, Jessica Eschenbach, Christoph Dieterich · 2021 · Journal of Molecular and Cellular Cardiology
  49. Nicotinamide promotes cardiomyocyte derivation and survival through kinase inhibition in human pluripotent stem cells
    Ya Meng, Chengcheng Song, Zhili Ren, Xiaohong Li, Xiangyu Yang, Nana Ai, Yang Yang, Dongjin Wang, Meixiao Zhan, Jiaxian Wang et al. · 2021 · Cell Death and Disease
  50. Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Shane Rui Zhao, Gema Mondéjar‐Parreño, Dong Li, Mengcheng Shen, Joseph C. Wu · 2022 · Journal of Visualized Experiments
  51. Multiple mechanisms underlie increased cardiac late sodium current
    Brett M. Kroncke, Tao Yang, Dan M. Roden · 2019 · Heart Rhythm
  52. Doxorubicin induces caspase-mediated proteolysis of KV7.1
    Anne Strigli, Christian Raab, Sabine Hessler, Tobias Huth, Adam J.T. Schuldt, Christian Alzheimer, Thomas Friedrich, Paul W. Burridge, Mark Luedde, Michael Schwake · 2018 · Communications Biology
  53. Proteomic Profiling Reveals Roles of Stress Response, Ca2+ Transient Dysregulation, and Novel Signaling Pathways in Alcohol‐Induced Cardiotoxicity
    Rui Liu, Fangxu Sun, Parvin Forghani, Lawrence C. Armand, Antonio Rampoldi, Dong Li, Ronghu Wu, Chunhui Xu · 2020 · Alcoholism Clinical and Experimental Research
  54. Minimal contribution of IP3R2 in cardiac differentiation and derived ventricular-like myocytes from human embryonic stem cells
    Peng Zhang, Jijun Huang, Kunfu Ouyang, Liang He, Miaoling Li, Yijie Wang, Huang‐Tian Yang · 2020 · Acta Pharmacologica Sinica
  55. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells
    Fabian Zanella, Farah Sheikh · 2014 · Methods in molecular biology
  56. Many Cells Make Life Work—Multicellularity in Stem Cell-Based Cardiac Disease Modelling
    Brian Wang, Worrapong Kit‐Anan, Cesare M. Terracciano · 2018 · International Journal of Molecular Sciences
  57. Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease
    Mohamed Ameen, Laksshman Sundaram, Abhimanyu Banerjee, Mengcheng Shen, Soumya Kundu, Surag Nair, Anna Shcherbina, Mingxia Gu, Kitchener D. Wilson, Avyay Varadarajan et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Reprogramming and multi-lineage transdifferentiation attenuate the tumorigenicity of colorectal cancer cells
    Tongtong Guo, Juan Wang, Maogui Pang, Wanning Liu, Xiaohui Zhang, Ahui Fan, Hengtao Liu, Qianqian Liu, Tianying Wei, Cunxi Li et al. · 2023 · Journal of Biological Chemistry
  59. Trisomy 21 Alters Cell Proliferation and Migration of iPSC-Derived Cardiomyocytes on Type VI Collagen
    Rachel S. Reeser, A. Salazar, Kendra M. Prutton, James R. Roede, Mitchell C. VeDepo, Jeffrey G. Jacot · 2024 · Cellular and Molecular Bioengineering
  60. In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment
    Mark C. Daley, Marjory Moreau, Peter Bronk, Jeffrey W. Fisher, Celinda M. Kofron, Ulrike Mende, Patrick D. McMullen, Bum‐Rak Choi, Kareen Coulombe · 2024 · Toxicological Sciences
  61. Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening
    Yuhong Wang, Tingting Liu, Yanping Guo, Shuo-ji Zhu, Ziming Liao, Jia-mei Song, Xi-ming Zhu, Jia-liang Liang, Moussa Ide Nasser, Nan-bo Liu et al. · 2024 · Bioactive Materials
  62. Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy
    Shan Gao, Dan Li, Bingkai Wang, Hao Zhang, Lu Chen · 2025 · Frontiers in Cardiovascular Medicine
  63. Synthetic hydrogels support robust and reproducible cardiomyocyte differentiation
    Margot J. Amitrano, Mina Cho, Eva M. Coughlin, Sean P. Palecek, William L. Murphy · 2025 · Biomaterials Science
  64. Application of human cardiac organoids in cardiovascular disease research
    Hongyan Zhang, Peng Qu, Jun Liu, Panke Cheng, Qian Lei · 2025 · Frontiers in Cell and Developmental Biology
  65. Enhancing human pluripotent stem cell differentiation to cardiomyocytes through cardiac progenitor reseeding and cryopreservation
    Austin K. Feeney, Aaron D. Simmons, Claire J Peplinski, Xiaotian Zhang, Sean P. Palecek · 2025 · iScience
  66. Generation and purification of iPSC-derived cardiomyocytes for clinical applications
    Melanie Generali, Debora Kehl, Dankwart Meier, Dennis Zorndt, Kirstin Atrott, Hirohide Saito, Maximilian Y. Emmert, SP Hoerstrup · 2025 · Stem Cell Research & Therapy
  67. Selective serotonin reuptake inhibitors induce cardiac toxicity through dysfunction of mitochondria and sarcomeres
    Yawei Shen, Cameron E. Brown, Xiao Li, Peng Zhang, Stacey R McGee, Søren C. Spina, J. Ricardo Loret de Mola, Joanna L. Fiddler, Haodi Wu, Qing Liu · 2025 · Communications Biology
  68. AI-guided laser purification of human iPSC-derived cardiomyocytes for next-generation cardiac cell manufacturing
    Prakaimuk Saraithong, Peyton Krajcarski, Yukako Kusaka, Moé Yamada, Junichi Matsumoto, Hailey Cunningham, Sama Salih, Darby Jones, Devika Baddhan, Christian Hausner et al. · 2025 · Communications Biology
  69. Alternative splicing dynamics during human cardiac development in vivo and in vitro
    Beatriz Gomes-Silva, Marta Furtado, Marta Ribeiro, Sandra Martins, Teresa Carvalho, André Ventura-Gomes, Henrike Maatz, Pragati Parakkat, Claudia Crocini, Michael Gotthardt et al. · 2026 · Stem Cell Reports
  70. “The state of the heart”: Recent advances in engineering human cardiac tissue from pluripotent stem cells
    Dario Sirabella, Elisa Cimetta, Gordana Vunjak‐Novakovic · 2015 · Experimental Biology and Medicine
  71. Disease Modeling of Pituitary Adenoma Using Human Pluripotent Stem Cells
    Ryusaku Matsumoto, Hidetaka Suga, Hiroshi Arima, Takuya Yamamoto · 2022 · Cancers
  72. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes
    Marzia De Bortoli, Viviana Meraviglia, Katarina Macková, Laura Sophie Frommelt, Eva König, Johannes Rainer, Chiara Volani, Patrizia Benzoni, Maja Schlittler, Giada Cattelan et al. · 2023 · Computational and Structural Biotechnology Journal
  73. Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes
    Yu Gao, Liping Su, Yuhua Wei, Shi Hua Tan, Zhenyu Hu, Zhonghao Tao, Jean‐Paul Kovalik, Tuck Wah Soong, Jianyi Jay Zhang, Jun Pu et al. · 2023 · Theranostics
  74. Wnt dose escalation during the exit from pluripotency identifies tranilast as a regulator of cardiac mesoderm
    Zhixuan Wu, Sophie Shen, Dalia Mizikovsky, Yuanzhao Cao, Marina Naval-Sánchez, Siew Zhuan Tan, Yanina D. Álvarez, Yuliangzi Sun, Xiaoli Chen, Qiongyi Zhao et al. · 2024 · Developmental Cell
  75. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor
    Cláudia Correia, Jonas Christoffersson, Sandra Tejedor, Saïd El-Haou, Meztli L. Matadamas-Guzman, Syam Nair, Pierre Dönnes, Gentian Musa, Mattias Rohman, Monika Sundqvist et al. · 2024 · Cells
  76. Induced pluripotent stem cell-derived cardiomyocytes: A platform for testing for drug cardiotoxicity
    Daniel Bernstein · 2017 · Progress in Pediatric Cardiology
  77. Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function
    Arne A.N. Bruyneel, Wesley L. McKeithan, Dries A. M. Feyen, Mark A. Mercola · 2018 · Current Cardiology Reports
  78. Adverse effects of nicotine on cardiogenic differentiation from human embryonic stem cells detected by single-cell RNA sequencing
    Biaochuan He, Jing Chen, Miao Tian, Jimei Chen, Chengbin Zhou, Yanqiu Ou, Sheng Wang, Xiaohong Li, Jian Zhuang · 2020 · Biochemical and Biophysical Research Communications
  79. In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs)
    Agnieszka D’Antonio‐Chronowska, Matteo D’Antonio, Kelly A. Frazer · 2020 · BIO-PROTOCOL
  80. Fabrication and characterization of a thick, viable bi-layered stem cell-derived surrogate for future myocardial tissue regeneration
    Daniëlle Pretorius, Asher M. Kahn-Krell, Wesley C. LaBarge, Xi Lou, Ramaswamy Kannappan, Andrew E. Pollard, Vladimir G. Fast, Joel L. Berry, Alan W. Eberhardt, Jianyi Jay Zhang · 2020 · Biomedical Materials
  81. Yulink, predicted from evolutionary analysis, is involved in cardiac function
    Ming-Wei Kuo, Hsiu-Hui Tsai, Sheng-Hung Wang, Yi-Yin Chen, A. L. Yu, John Yu · 2021 · Journal of Biomedical Sciences
  82. Isolation of human ESC-derived cardiac derivatives and embryonic heart cells for population and single-cell RNA-seq analysis
    Federica Santoro, Kenneth R. Chien, Makoto Sahara · 2021 · STAR Protocols
  83. Chalcone‐Supported Cardiac Mesoderm Induction in Human Pluripotent Stem Cells for Heart Muscle Engineering
    Farah S. Raad, Taukeer A. Khan, Tilman Uli Esser, James E. Hudson, Bhakti Irene Seth, Buntaro Fujita, Gandamala Ravi, Lutz Friedjan Tietze, Wolfram‐Hubertus Zimmermann · 2021 · ChemMedChem
  84. Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies
    Jennifer Zhang, Oscar Hou In Chou, Yiu-Lam Tse, Kwong‐Man Ng, Hung‐Fat Tse · 2021 · International Journal of Molecular Sciences
  85. Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human Pluripotent Stem Cells
    Benjamin B. Johnson, Johannes Reinhold, Terri L. Holmes, Jamie A Moore, Verity Cowell, Andreia Sofia Bernardo, Stuart A. Rushworth, Vassilios S. Vassiliou, James G.W. Smith · 2021 · Metabolites
  86. Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes
    Dennis Schade, Lauren Drowley, Qing‐Dong Wang, Alleyn T. Plowright, Boris Greber · 2022 · Bioorganic & Medicinal Chemistry
  87. Targeted Analysis of circRNA Expression in Patient Samples by Lexo-circSeq
    Isabel S. Naarmann‐de Vries, Jessica Eschenbach, Sarah Schudy, Benjamin Meder, Christoph Dieterich · 2022 · Frontiers in Molecular Biosciences
  88. Differential Effects of Beta-Hydroxybutyrate Enantiomers on Induced Pluripotent Stem Derived Cardiac Myocyte Electrophysiology
    Matthew Klos, Wanqing Hou, Bernard Nsengimana, Shiwang Weng, Chuyun Yan, Suowen Xu, Eric J. Devaney, Shuxin Han · 2022 · Biomolecules
  89. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies
    Marissa Joy Stutzman, Xiaozhi Gao, Maengjo Kim, Dan Ye, Wei Zhou, David J. Tester, John R. Giudicessi, Kevin Shannon, Michael John Ackerman · 2023 · Heart Rhythm
  90. Simple insoluble cues specify stem cell differentiation
    P.C. Dave P. Dingal, Rebecca G. Wells, Dennis E. Discher · 2014 · Proceedings of the National Academy of Sciences
  91. Programming cells for cardiac repair
    Rocco Romagnuolo, Michael A. Laflamme · 2017 · Current Opinion in Biotechnology
  92. Pluripotent and Mesenchymal Stem Cells—Challenging Sources for Derivation of Myoblast
    Karolina Archacka, Edyta Brzóska, Maria A. Ciemerych, Areta M. Czerwińska, Iwona Grabowska, Kamil Kowalski, Małgorzata Zimowska · 2017 · Springer eBooks
  93. Design of synthetic microenvironments to promote the maturation of human pluripotent stem cell derived cardiomyocytes
    Rui Zhang, Tianwei Guo, Yu Han, Hongxin Huang, Jiamin Shi, Jiaxuan Hu, Hongjiao Li, Jianlin Wang, Amina Saleem, Ping Zhou et al. · 2020 · Journal of Biomedical Materials Research Part B Applied Biomaterials
  94. Mitochondrial Medicine: Genetic Underpinnings and Disease Modeling Using Induced Pluripotent Stem Cell Technology
    Parisa K Kargaran, Diogo Mosqueira, Tamás Kozicz · 2021 · Frontiers in Cardiovascular Medicine
  95. Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells
    Xuan Ni, Zhuangzhuang Yang, Lingqun Ye, Xinglong Han, Dandan Zhao, Fengyue Ding, Nan Ding, Hongchun Wu, Miao Yu, Guang‐Yin Xu et al. · 2021 · Acta Pharmacologica Sinica
  96. Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs
    Mark Johnson, Jorge Gomez‐Galeno, Daniel Ryan, Karl J. Okolotowicz, Wesley L. McKeithan, Kevin J. Sampson, Robert S. Kass, Mark A. Mercola, John Richard Cashman · 2021 · Bioorganic & Medicinal Chemistry Letters
  97. Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
    Takeshi Tokuyama, Razan Elfadil Ahmed, Nawin Chanthra, Tatsuya Anzai, Hideki Uosaki · 2021 · Biology
  98. Regulatory aspects of small molecule drugs for heart regeneration
    Kathleen E. Rodgers, Anna Papinska, Nicholas M. Mordwinkin · 2015 · Advanced Drug Delivery Reviews
  99. CD151 expression marks atrial- and ventricular- differentiation from human induced pluripotent stem cells
    Misato Koakutsu, Kenji Miki, Yuki Naka, Masako Sasaki, Takayuki Wakimizu, Stephanie C. Napier, Chikako Okubo, Megumi Narita, Misato Nishikawa, Reo Hata et al. · 2024 · Communications Biology
  100. Bridging the Gap: Advances and Challenges in Heart Regeneration from In Vitro to In Vivo Applications
    Tatsuya Watanabe, Naoyuki Hatayama, Marissa Z. Guo, Satoshi Yuhara, Toshiharu Shinoka · 2024 · Bioengineering